Literature DB >> 26341522

Legacy of blood: does prasugrel inhibit megakaryocytes and do juvenile platelets inherit this inhibition?

Carlos G Santos-Gallego1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26341522      PMCID： PMC4800700          DOI： 10.3324/haematol.2015.132134

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  21 in total

1.  Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system.

Authors:  P Michael Ho; Thomas T Tsai; Tracy Y Wang; Susan M Shetterly; Christina L Clarke; Alan S Go; Art Sedrakyan; John S Rumsfeld; Eric D Peterson; David J Magid
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-03-30

2.  2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Alice K Jacobs
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

Review 3.  Anti-platelet drugs: do they affect megakaryocytes?

Authors:  J P Cazenave; C Gachet
Journal:  Baillieres Clin Haematol       Date:  1997-02

4.  The Platelet Activity After Clopidogrel Termination (PACT) study.

Authors:  Andrew L Frelinger; Marc R Barnard; Marsha L Fox; Alan D Michelson
Journal:  Circ Cardiovasc Interv       Date:  2010-08-24       Impact factor: 6.546

5.  A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment.

Authors:  Dirk Sibbing; Julia Stegherr; Siegmund Braun; Julinda Mehilli; Stefanie Schulz; Melchior Seyfarth; Adnan Kastrati; Nicolas von Beckerath; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2010-02-09       Impact factor: 24.094

6.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

7.  Absorption, distribution and excretion of the new thienopyridine agent prasugrel in rats.

Authors:  K Hagihara; A Kurihara; K Kawai; M Kazui; M Takahashi; K Kawabata; N A Farid; T Ikeda
Journal:  Xenobiotica       Date:  2007-07       Impact factor: 1.908

8.  Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.

Authors:  Sasidhar Guthikonda; Carlos L Alviar; Muthiah Vaduganathan; Mehmet Arikan; Armando Tellez; Timothy DeLao; Juan F Granada; Jing-Fei Dong; Neal S Kleiman; Eli I Lev
Journal:  J Am Coll Cardiol       Date:  2008-08-26       Impact factor: 24.094

9.  Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old.

Authors:  G L Dale; P Friese; L A Hynes; S A Burstein
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

10.  Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.

Authors:  P Michael Ho; Eric D Peterson; Li Wang; David J Magid; Stephan D Fihn; Greg C Larsen; Robert A Jesse; John S Rumsfeld
Journal:  JAMA       Date:  2008-02-06       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.